Click to view your profile
Click to search for condition or expert
Click to open main menu
Ulcerative Colitis Latest Advances
Find the Latest Research About Ulcerative Colitis
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 02/19/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 483 publications
See more filters
Impact of Synbiotic Therapy on the Quality of Life in Patients with Mild-to-Moderately Active Ulcerative Colitis.
Condition:
Mild-to-Moderately Active Ulcerative Colitis
Journal:
Journal of gastrointestinal and liver diseases : JGLD
Treatment Used:
Synbiotic Therapy
Number of Patients:
40
Published:
December 19, 2022
VIEW PUBLICATION
Japanese pediatric patient with refractory steroid-resistant ulcerative colitis successfully treated with Tofacitinib: A case report.
Condition:
Japanese Pediatric Patient with Refractory Steroid-Resistant Ulcerative Colitis (UC)
Journal:
Medicine
Treatment Used:
Tofacitinib
Number of Patients:
1
Published:
November 18, 2022
VIEW PUBLICATION
Ulcerative colitis complicated by pyoderma gangrenosum and multiple aseptic abscesses.
Condition:
Ulcerative Colitis (UC) with Pyoderma Gangrenosum and Aseptic Abscesses
Journal:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
Treatment Used:
Antibiotics, Apheresis, and Prednisolone
Number of Patients:
1
Published:
November 09, 2022
VIEW PUBLICATION
Filgotinib for moderately to severely active ulcerative colitis.
Condition:
Moderate to Severely Active Ulcerative Colitis (UC)
Journal:
Expert review of gastroenterology & hepatology
Treatment Used:
Filgotinib
Number of Patients:
0
Published:
October 24, 2022
VIEW PUBLICATION
Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: A systematic review and meta-analysis.
Condition:
Autoimmune and Autoinflammatory Diseases
Journal:
Frontiers in immunology
Treatment Used:
Fecal Microbiota Transplantation
Number of Patients:
0
Published:
October 17, 2022
VIEW PUBLICATION
Efficacy and safety of vedolizumab for inflammatory bowel diseases: A systematic review and meta-analysis of randomized controlled trials.
Condition:
Inflammatory Bowel Diseases
Journal:
Medicine
Treatment Used:
Vedolizumab
Number of Patients:
4268
Published:
October 12, 2022
VIEW PUBLICATION
Endoscopic Treatment of Postoperative Bleeding, Bezoars, and Foreign Bodies.
Condition:
Postoperative Bleeding, Bezoars, and Foreign Bodies
Journal:
Gastrointestinal endoscopy clinics of North America
Treatment Used:
Endoscopic Treatment
Number of Patients:
0
Published:
October 06, 2022
VIEW PUBLICATION
In active UC, upadacitinib induced and maintained remission.
Condition:
Active Ulcerative Colitis (UC)
Journal:
Annals of internal medicine
Treatment Used:
Upadacitinib
Number of Patients:
0
Published:
October 03, 2022
VIEW PUBLICATION
Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: A pilot, randomized, double-blind, placebo-controlled study.
Condition:
Ulcerative Colitis (UC)
Journal:
Clinical nutrition ESPEN
Treatment Used:
Probiotic Supplementation
Number of Patients:
30
Published:
October 02, 2022
VIEW PUBLICATION
Real-world evidence of quality of life improvement in patients with distal ulcerative colitis treated by mesalazine: the Quartz study.
Condition:
Distal Ulcerative Colitis (UC)
Journal:
European journal of gastroenterology & hepatology
Treatment Used:
Mesalazine
Number of Patients:
93
Published:
September 27, 2022
VIEW PUBLICATION
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension.
Condition:
Moderate-to-Severe and Active Ulcerative Colitis
Journal:
The lancet. Gastroenterology & hepatology
Treatment Used:
ABX464 (Obefazimod)
Number of Patients:
254
Published:
September 08, 2022
VIEW PUBLICATION
Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases.
Condition:
Inflammatory Bowel Diseases (IBDs)
Journal:
Frontiers in immunology
Treatment Used:
Mesenchymal Stem/Stromal Cells (MSCs)
Number of Patients:
0
Published:
August 22, 2022
VIEW PUBLICATION
Showing 1-12 of 483
Next
Last Updated: 02/19/2023